Skip to main content
Premium Trial:

Request an Annual Quote

No, Really, We'd Love to Have You Come ... But Not Stay

The New York Times reports on the visa crunch here in the US, leading off with a look at microRNA researcher Alena Shkumatava at the Whitehead Institute. Shkumatava "is among the several hundred thousand students who need a visa to study in the United States," the article says. "People at universities and scientific organizations who study the issue say they have heard increasing complaints of visa delays since last fall, particularly for students in science engineering and other technical fields." There's increasing concern that such problems will drive away foreign students from US institutions.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.